Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 25285812)

Published in JAMA Neurol on December 01, 2014

Authors

Annalese G Neuenschwander1, Khanh K Thai1, Karla P Figueroa1, Stefan M Pulst1

Author Affiliations

1: Department of Neurology, University of Utah, Salt Lake City.

Articles cited by this

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 15.38

Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature (2010) 5.26

Rethinking ALS: the FUS about TDP-43. Cell (2009) 4.71

Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet (1996) 4.16

Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet (1996) 3.26

Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet (1996) 3.07

Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum Mol Genet (2009) 2.50

Spinocerebellar ataxia 2 (SCA2). Cerebellum (2008) 1.84

Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. Am J Epidemiol (1997) 1.73

Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology (2011) 1.72

The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol (2013) 1.61

Late-onset SCA2: 33 CAG repeats are sufficient to cause disease. Neurology (2000) 1.56

Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data. BMC Med Res Methodol (2007) 1.47

Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol (2000) 1.36

Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset. Brain (2005) 1.28

Occupational exposure to magnetic fields in case-referent studies of neurodegenerative diseases. Scand J Work Environ Health (2002) 1.19

Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis. Arch Neurol (2011) 1.13

ATXN-2 CAG repeat expansions are interrupted in ALS patients. Hum Genet (2011) 1.12

The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect. Neurobiol Dis (2011) 1.12

Amyotrophic lateral sclerosis and spinocerebellar ataxia type 2 in a family with full CAG repeat expansions of ATXN2. JAMA Neurol (2013) 1.06

Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. II. Diet. Am J Epidemiol (2000) 0.99

Meta-analysis of incidence of rare events. Stat Methods Med Res (2012) 0.98

ATAXIN2 CAG-repeat length in Italian patients with amyotrophic lateral sclerosis: risk factor or variant phenotype? Implication for genetic testing and counseling. Neurobiol Aging (2012) 0.95

Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts. Neurobiol Aging (2011) 0.95

ATXN2 and its neighbouring gene SH2B3 are associated with increased ALS risk in the Turkish population. PLoS One (2012) 0.94

Pathoanatomy of cerebellar degeneration in spinocerebellar ataxia type 2 (SCA2) and type 3 (SCA3). Cerebellum (2012) 0.88

ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosis. Neurobiol Aging (2013) 0.87

De novo mutations in ataxin-2 gene and ALS risk. PLoS One (2013) 0.86

Estimation of the age at onset in spinocerebellar ataxia type 2 Cuban patients by survival analysis. Clin Genet (2009) 0.82

Genetic variance in the spinocerebellar ataxia type 2 (ATXN2) gene in children with severe early onset obesity. PLoS One (2009) 0.81